Industry News

Apr 22, 2014

Malfunction in molecular 'proofreader' prevents repair of UV-induced DNA damage

Malfunctions in the molecular "proofreading" machinery, which repairs structural errors in DNA caused by ultraviolet (UV) light damage, help explain why people who have the disease xeroderma... Read More
Apr 22, 2014

Vanderbilt study tracks new lung cancer drug target

Researchers at Vanderbilt University have identified a potential new drug target in subtypes of lung cancer that are difficult to treat. Read More
Apr 22, 2014

FDA approves Cyramza for stomach cancer

The U.S. Food and Drug Administration has approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the... Read More
Apr 22, 2014

Link between chronic inflammation and 'high-grade' prostate cancer

Men who show signs of chronic inflammation in non-cancerous prostate tissue may have nearly twice the risk of actually having prostate cancer than those with no inflammation, according to results of... Read More
Apr 22, 2014

Link uncovered between Down syndrome and leukemia

Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why. Read More
Apr 22, 2014

As genomic medicine expands, computational method dramatically speeds up estimates of gene expression

With gene expression analysis growing in importance for both basic researchers and medical practitioners, researchers at Carnegie Mellon University and the University of Maryland have developed a new... Read More
Apr 22, 2014

The source identified of most cases of invasive bladder cancer

A single type of cell in the lining of the bladder is responsible for most cases of invasive bladder cancer, according to researchers at the Stanford University School of Medicine. Read More
Apr 22, 2014

Discovery of cancer stem cells linked to drug resistance could impact treatment for lung, pancreas and breast cancers

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Read More
Apr 22, 2014

Stigma and related emotional effects experienced by lung cancer patients

It's not uncommon these days to find a colored ribbon representing a disease. A pink ribbon is well known to signify breast cancer. But what color ribbon does one think of with lung cancer? Read More
Apr 22, 2014

Living devices may selectively kill cancer cells without disrupting healthy cells

A Northwestern synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other... Read More
Next Page